Literature DB >> 19859669

[Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut].

H Löffler1, C Kosel, H Cremer, W Kachel.   

Abstract

Small hemangiomas sometimes produce large findings. Depending on localization, local therapy is not always possible. According to a case described in the literature, a hemangioma in an infant regressed following cardiologically indicated Propranolol. This experience has been used in numerous other cases since then and Propranolol has been administered for the indication of a hemangioma. Even in cases of very large hemangiomas rapid improvement has been observed; successful results persisted even after discontinuation. Particularly in cases of problematic localisation, such as in the eye area, prompt therapeutic success is important in order to prevent blindness. Relevant studies are in the preparatory phase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19859669     DOI: 10.1007/s00105-009-1856-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  9 in total

1.  Retrospective clinical comparison of hemangioma treatment by flashlamp-pumped (585 nm) and frequency-doubled Nd:YAG (532 nm) lasers.

Authors:  C Raulin; B Greve
Journal:  Lasers Surg Med       Date:  2001       Impact factor: 4.025

2.  Hemangiomas in infancy and childhood. S 2k Guideline of the German Society of Dermatology with the working group Pediatric Dermatology together with the German Society for Pediatric Surgery and the German Society for Pediatric Medicine.

Authors:  Rainer Grantzow; Peter Schmittenbecher; Hansjörg Cremer; Peter Höger; Jochen Rössler; Henning Hamm; Ulrich Hohenleutner
Journal:  J Dtsch Dermatol Ges       Date:  2008-02-25       Impact factor: 5.584

3.  Life-threatening infantile haemangioma: a dramatic response to propranolol.

Authors:  T Theletsane; A Redfern; O Raynham; T Harris; N S Prose; N P Khumalo
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-05-06       Impact factor: 6.166

4.  More on propranolol for hemangiomas of infancy.

Authors:  Elaine C Siegfried; William J Keenan; Saadeh Al-Jureidini
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

Review 5.  [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].

Authors:  C Léauté-Labrèze; A Taïeb
Journal:  Ann Dermatol Venereol       Date:  2008-11-20       Impact factor: 0.777

6.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

7.  Cryosurgery for hemangiomas.

Authors:  H Cremer
Journal:  Pediatr Dermatol       Date:  1998 Sep-Oct       Impact factor: 1.588

Review 8.  Update on hemangiomas and vascular malformations of the head and neck.

Authors:  Behfar Eivazi; Mircia Ardelean; Wolfgang Bäumler; Hans-Peter Berlien; Hansjörg Cremer; Ravindhra Elluru; Peter Koltai; Jan Olofsson; Gresham Richter; Bernhard Schick; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-04       Impact factor: 2.503

Review 9.  Vincristine as a treatment for a large haemangioma threatening vital functions.

Authors:  S L Fawcett; I Grant; P N Hall; A W R Kelsall; J C Nicholson
Journal:  Br J Plast Surg       Date:  2004-03
  9 in total
  4 in total

1.  [Infantile hemangioma. Successful treatment with propranolol].

Authors:  J Baetz; S Eigelshoven; J Marquard; D Bruch-Gerharz; B Homey; T Meissner
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

2.  [Successful treatment of orbital capillary hemangioma with propranolol].

Authors:  C Mai; A Vega-Pérez; M Koch; E Bertelmann
Journal:  Ophthalmologe       Date:  2011-04       Impact factor: 1.059

Review 3.  Cutaneous lesions of the nose.

Authors:  Michael Sand; Daniel Sand; Christina Thrandorf; Volker Paech; Peter Altmeyer; Falk G Bechara
Journal:  Head Face Med       Date:  2010-06-04       Impact factor: 2.151

Review 4.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.